Home / Resources / Every Match Matters: Strategies for More Effective Patient Recruitment
ON-DEMAND WEBINAR | JUL 16, 2026

Every Match Matters: Strategies for More Effective Patient Recruitment

With decades of experience across clinical planning, patient identification, and recruitment strategy, Citeline brings together data, Al, and human expertise to help sponsors find the right patients — sooner. This session covers the practical strategies and end-to-end capabilities that are making recruitment faster, more precise, and more predictable.

Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

What You Will Get from This Session

  • A look at why enrollment keeps falling short — the structural, clinical, and operational barriers that prevent eligible patients from reaching the trials that could help them
  • A data-driven approach to smarter matching — how AI and RWD, including linked EMR records, claims, lab data, and clinician-reviewed algorithms, can surface protocol-matched patients earlier and more reliably than traditional methods
  • Strategies you can apply to your trial — a practical overview of how patient identification, feasibility, and patient journey insights work together across complex oncology and rare disease protocols
  • Proof it works — real-world examples showing how this approach has helped sponsors overcome recruitment roadblocks, accelerate enrollment timelines, and find the right sites in places traditional feasibility would never look
  • A clear next step — whether you are in early planning, mid-recruitment, or rethinking your strategy entirely, you’ll leave with concrete actions and an understanding of how Citeline's end-to-end recruitment capabilities can support your specific situation

Featured speakers

Headshot image of Madeline Naylor

Madeline Naylor

Chief Clinician RWD, Norstella

Norstellaのチーフ・クリニシャンであるDr. Madeline Naylorは、臨床およびリアルワールドデータの専門知識を活かし、クライアントおよびその先にいる患者に対して、最高品質かつ革新的なソリューションを提供しています。
彼女はこれまで10年間にわたり、病院やクリニックにおいて学術・商業両面の研究を主導・実施しており、世界最大規模の若年性アルツハイマー病研究の推進にも貢献してきました。

Madelineは神経疾患領域を専門としながらも、幅広い疾患領域において豊富な経験を有しています。
セントラル・メイン心血管センターでは2年間勤務し、同センター初となる医療機器治験「経カテーテル大動脈弁置換術（TAVR）」の立ち上げを主導しました。
また、がん領域にも強い関心を持ち、がん診断がもたらす分子レベルの影響とメンタルヘルスへの影響の両面から研究を行っています。

ヘルスサイエンス博士号（Doctor of Health Science）および医科学修士号（Master of Medical Science）を取得しており、臨床研究コーディネーター認定（Clinical Research Coordinator Certification）をAssociation of Clinical Research Professionals（ACRP）より取得しています。

Headshot image of Suzanne Caruso

Suzanne Caruso

President, Norstella

Suzanne Caruso is a senior business executive and clinical trial study start-up expert with over 15 years of experience in the pharmaceutical industry. As the General Manager of Clinical & Regulatory at Norstella, she leverages her expertise in artificial intelligence (AI), data analytics, and innovative trial operational models to drive efficiency for large pharma, biotech, and CRO companies. Suzanne has held roles at Veeva Systems, WCG, GSK, and Novartis and has served as a subject matter expert and adviser to over 50 organizations.